ICICI Securities Ltd | Retail Equity Research Revenues grew ~22% YoY to | 1681 crore (I-direct estimate: | 1623 crore) on the back of 16% growth in the healthcare business to | 892 crore (I-direct estimate: | 885 crore) and 29% growth in the pharmacy business to | 789 crore (I-direct estimate: | 739 crore) EBITDA margins declined 119 bps YoY to 11.5% against I-direct estimates of 12.7% mainly due to higher contribution from low margin new hospitals as well as one-offs 1) cost related to VIP...